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tected with large samples. Nevertheless, it is an indication and should be developed in any future survey.
By analyzing a wide range of teleost species (plus one reptile and two mammals), we have clearly demonstrated the universality of the five new intronic primer sets designed in this study. Rich profiles were observed when several PCR loci were amplified with one intronic system [i.e., several genes or pseudogenes (3, 7) ]. However, results could become unreadable when too many loci were not specifically amplified, leading to overloaded profiles (not usable data). Despite these exceptions, the markers are powerful for species identification by analysis of easily readable profiles; two or three of them have to be considered together to obtain a definitive diagnosis.
These primers are also promising for population genetics, as a rich polymorphism was observed that expressed several alleles discriminated by length polymorphism on agarose or acrylamide gels. They are already being used in as yet unpublished population genetic research (11, 12) on several fish species and are providing informative data.
We showed here the usefulness of these new EPIC-PCR genetic markers for fish identification at the species and population level by analyzing the length polymorphism of the doublestranded DNA. Depending on the fragment length obtained, a single-strand analysis (7) or SSCP (9) when the fragments are short, or a restriction fragment length polymorphism analysis when PCR fragments are monomorphic (5), could be more suitable alternatives for expressing the polymorphism. 
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The expression of recombinant proteins in bacteria is a key tool for researchers interested in biochemical and biophysical analyses of protein functions in vitro. However, many key targets, especially eukaryotic proteins, do not express well for a variety of reasons (e.g., protein misfolding or the addition or lack of posttranslational modification). One such protein is the double-stranded RNA (dsRNA)-activated protein kinase named PKR, which has been implicated in a variety of roles from the control of normal cell growth and differentiation to apoptosis (1) . One of the most widely studied roles is the part PKR plays in the antiviral effects of interferon (IFN). Normally present in most mammalian cells at low levels, PKR expression is induced several-fold by IFN in response to viral infection (2) and, once activated, phosphorylates its target, the eukaryotic translation initiation factor 2 (eIF2) on serine 51 of the α-subunit (3). This has the effect of increasing the affinity of the inactive guanosine diphosphate-bound form of eIF2 for BENCHMARKS the guanidine exchange factor (eIF2B), which leads to a reduced pool of active eIF2 molecules and a cessation of general translation (4, 5) . Numerous viruses have evolved countermeasures to the effects of PKR using either short noncoding RNAs [e.g., adenovirus-associated RNA I (VA RNA I ) (6,7)] or viral proteins to inhibit its function.
The in vitro analysis of PKR function (activation and inhibition) and structure requires a source of active protein in a nonphosphorylated (i.e., nonactivated) form. While many studies have used the limited amounts of protein that can be purified from mammalian cell lines, one study has shown that a glutathione-S-transferase (GST)-PKR fusion protein can be expressed in Escherichia coli (8) . Ideally, the protein should be highly purified but free of additional tags (e.g., GST). To this end, human PKR cDNA was cloned into a vector from the IMPACT ® -CN System (New England Biolabs UK, Hitchin, UK) that uses an intein-chitin binding domain (CBD) fusion to give high protein purity and provides the target protein free of additional tags with the use of a single chromatographic step. PKR cDNA was PCR-amplified from plasmid pET-His-PKR using primers containing NdeI (forward) or XhoI (reverse) restriction sites and a 60:1 unit ratio of Taq and Pwo DNA polymerases (Roche Diagnostics, Lewes, UK). The amplified PCR product was ligated into a TA Cloning ® Vector (Invitrogen, Paisley, UK) before being transferred to the expression vector pTYB2 via the NdeI and XhoI restriction sites (pTYB2/PKR). Lambda-protein phosphatase (λ-PP) cDNA was PCRamplified from λ DNA using forward primer 5′-CTGCAGTAAGAAGGAG-ATAAAGAGATGCGC-3′ (PstI restriction site, italics; Shine-Dalgarno region, bold) and reverse primer 5′-GGTGCTAG-CCTGCAGTCATGCGCCTTC-3′ (PstI restriction site, italics). The PCR product was ligated into pTYB2/PKR (via a TA Cloning Vector) at a PstI site downstream of the Saccharomyces cerevisiae vacuolar membrane ATPase (Sce VMA) intein/ CBD coding region to create the expression vector pTYB2/PKR(PP) ( Figure  1A) . At each step, the correct insert orientations and sequences were confirmed by automated DNA sequencing.
A variety of E. coli strains for the expression of PKR and PKR(PP) (i.e., PKR with co-expression of λ-PP) were tested, including BL21(DE3) and its derivatives ER2566 (New England Biolabs; the strain supplied with the IMPACT-CN System), BL21 (DE3)-CodonPlus ® -RIL and -RP cells (Stratagene Europe, Amsterdam, The Netherlands), pLysS, and pLysE. The level of protein expression was determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) with Coomassie ® staining or immunoblotting with anti-PKR antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA). The significant expression of PKR and PKR(PP) proteins was observed only with the BL21(DE3)-CodonPlus-RIL strain (data not shown). Liquid cultures were grown at 37°C in LB medium to mid-log phase before the induction of protein expression by 0.3 mM isopropyl-β-D-thiogalactoside (IPTG; Melford Laboratories Ltd., Ipswich, UK) and further growth at 30°C for 6 h or at 12°-15°C for 18 h. The buffer for cell lysis, protein binding to chitin resin, and washing of resin contained 20 mM HEPES, pH 6.5, 1 M NaCl, 1 mM EDTA, 0.1% Triton ® X-100, and 10% glycerol. To induce the intein self-cleavage reaction, the resin was quickly flushed with the same solution but at pH 8.5, containing 50 mM dithiothreitol (DTT), and incubated at 4°C for 12-18 h. The typical yield from a 1-L bacterial culture and purification of PKR or PKR(PP) protein was 0.3-0.5 mg ( Figure 1B) .
The activation of PKR by dsRNA is relatively well understood. The binding of dsRNA to the two N-terminal dsRNA binding domains of PKR causes a conformational change and activation by the autophosphorylation of PKR dimers (9, 10) . Because of the requirement for dimerization on dsRNA, PKR activation shows a characteristic response 
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to RNA concentration, increasing to a maximum from low RNA concentrations but falling again at higher concentrations. Following activation, PKR activity is no longer dependent on dsRNA. In vitro tests of PKR activation and function were conducted to assess the activity and phosphorylation state of the purified protein from the pTYB2/PKR and pTYB2/PKR(PP) vectors when they are expressed in BL21 (DE3)-CodonPlus-RIL cells. The PKR autophosphorylation and eIF2α phosphorylation were assayed in 10-µL reactions using poly(I) . poly(C) (Amersham Biosciences, Little Chalfont, UK) as a dsRNA activator with approximately 0.2 µg PKR or PKR(PP) and 0.5 µg eIF2α in the presence of [γ-32 P]ATP in 50 mM Tris buffer, pH 7.8, containing 50 mM KCl, 2 mM MgCl 2 , 2.5 mM DTT, 10 µM ATP, and 10% glycerol. The reaction mixtures were incubated at room temperature (25°C) for 10 min, and 5 µL 3× SDS-polyacrylamide loading dye for 10 min were added to stop the reaction. The proteins were resolved on 10% SDS-polyacrylamide gels, dried, and exposed to a phosphorimager screen (Amersham Biosciences). Purified PKR(PP) showed the expected maximum in activation in response to a range of poly(I) . poly(C) RNA concentrations and also phosphorylated its target protein eIF2α ( Figure 1C ). Further tests of PKR activation [e.g., using a structured RNA fragment from the IFN-γ mRNA 5′-untranslated region (11)] showed similar RNA concentrationdependent activation of PKR, while assays including VA RNA I show the expected inhibition of PKR at 20-50 µg/mL (data not shown; Reference 12). PKR protein expressed and purified under identical conditions but without the co-expression of λ-PP did not show any dependence on RNA concentration for the activation or eIF2α phosphorylation. The autophosphorylation of PKR is equal (and low; presumably many sites are already phosphorylated), and eIF2α is heavily phosphorylated at all concentrations and in the absence of activator poly(I) . poly(C) RNA.
The co-expression of PKR and λ-PP is clearly applicable to both the GST (8) and intein/CBD fusion systems. The benefit of the latter is the builtin removal of the tag to yield highly purified target protein. Thus, the combination of the co-expression with the λ-PP, IMPACT-CN system, and BL21 (DE3) CodonPlus-RIL strain allows for the preparation of active PKR in an unphosphorylated form and in quantities required for material-intensive in vitro biochemical and biophysical studies. However, this method should also be generally applicable for use in other expression systems if required or for other proteins that may be expressed in a (partially) phosphorylated form in bacteria.
